IRCT20240216061023N1RecruitingPhase 3
Comparing the efficacy of Toxin Botulinum type A with commercial names, MASPORT and DYSPORT in Benign Essential Blepharospasm: a Double blind Randomized Clinical Trial
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 19
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to no limit (—)
- Sex
- All
Inclusion Criteria
- •Clinically diagnosed with BEB
- •Without prior BTX-A injection in the previous 6 month
- •History of previous eyelid surgery
Exclusion Criteria
- •pregnancy or lactation
- •secondary causes of Blepharospasm
- •History of disorders of the neuromuscular junction like myasthenia gravis, Eaton-Lambert Syndrome, and psychological instability
- •prescription of antispastic, muscle relaxants or medications affecting neuromuscular junction transmission such as aminoglycosides
Investigators
Similar Trials
Completed
Phase 3
Comparative Efficacy of Botulinum Toxin Type A Injection Versus Placebo in the Correction of gummy Smile Between Khat Chewers and Non-Khat Chewers : A Randomized Clinical TrialExcessive gingival display ( gummy smile) measurment ( 3 - 8 mm ) due to hyperactive lip and short lip. measurment of the upper lip lenghand lip mobilitymeasurment of CEJCephalometric analysisGummy smile - Botox - Placebo - khat chewer - non khat chwereTCTR20240719004Hospital of Stomatology of Sana a University45
Completed
Not Applicable
Effects of Botulinum Toxin Type A in patients with chronic orofacial paiTemporomandibular Joint Dysfunction SyndromeC05.500.607.221.897RBR-8fsspyyFaculdade de Odontologia de Bauru, Universidade de São Paulo
Completed
Not Applicable
Assessment of efficacy of Botulinium toxin A for treatment of keloidkeloid scar.Hypertrophic scarIRCT2014071918533N1euronox company(Tehran reseller)20
Not yet recruiting
Phase 3
medical versus surgical treatment in idiopathic clubfoot patientsCTRI/2021/01/030466AIIMS RAIPUR
Completed
Not Applicable
A comparison of the effectiveness of botulinum toxin A and B in the treatment of adductor spasticity in adultservous System Diseases: Muscle spasticityNervous System DiseasesMuscle spasticityISRCTN92729017Department of Health